SAN DIEGO, May 25, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that MediciNova will present a company overview at the J.M. Dutton Health Science Small Cap Conference on May 30, 2007 at 10:10 a.m. Pacific time at the OMNI Hotel in San Francisco and at the Friedman Billings Ramsey Growth Conference on May 31, 2007 at 2:20 p.m. Eastern time at the Grand Hyatt in New York.
Live webcasts of the presentations can be accessed through MediciNova's webpage at www.medicinova.com. Archived versions of the presentations will be available for approximately 60 days following the events.
About MediciNova
MediciNova, Inc. is a publicly traded biopharmaceutical company that acquires well characterized small-molecule drugs through strategic alliances with Japanese and other international pharmaceutical companies and accelerates their development in a diversified portfolio of therapeutic product candidates targeting significant disease markets. MediciNova's pipeline, which includes six compounds in clinical testing, targets a variety of prevalent medical conditions, including multiple sclerosis, status asthmaticus, asthma, insomnia, cancer, preterm labor, urinary incontinence and thrombotic disorders. For more information on MediciNova, Inc., please visit www.medicinova.com.
The MediciNova, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3135